Market Cap 2.85B
Revenue (ttm) 1.04M
Net Income (ttm) -298.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28,693.27%
Debt to Equity Ratio 0.00
Volume 1,160,900
Avg Vol 1,000,504
Day's Range N/A - N/A
Shares Out 93.05M
Stochastic %K 30%
Beta 0.37
Analysts Strong Sell
Price Target $73.93

Latest News on CRNX

Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D.

May 30, 2024, 4:05 PM EDT - 10 months ago

Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D.


Under-the-radar biotech bets

Apr 3, 2024, 1:47 PM EDT - 1 year ago

Under-the-radar biotech bets

MRUS SNDX XBI